Publications by authors named "Dimas Tri Anantyo"

Claim this Profile
S
Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac®) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled study.
Yetty Movieta Nency, Rini Sekartini, Angga Wirahmadi, Suzy Maria, Nur Farhanah, Dimas Tri Anantyo

Hum Vaccin Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 study.
Martira Maddeppungeng, Asrawati Nurdin, Yetty Movieta Nency, Rini Sekartini, Bernie Endyarni Medise, Dimas Tri Anantyo

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial.
Asrawati Nurdin, Yetty Movieta Nency, Martira Maddeppungeng, Rini Sekartini, Rini Mulia Sari, Dimas Tri Anantyo

Vaccine· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protectivity and safety following recombinant hepatitis B vaccine with different source of bulk compared to hepatitis B (Bio Farma) vaccine in Indonesia.
Yetty M Nency, Farid Agung Rahmadi, Mulyono, Dimas Tri Anantyo, Nur Farhanah

Clin Exp Vaccine Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis